Hepatitis C distribution across diverse population groups in the Eastern Mediterranean Region: An umbrella review. [PDF]
Abdolahinia Z +5 more
europepmc +1 more source
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park +6 more
wiley +1 more source
Support for an Added-Sugar Menu-Labeling Policy among Key United States Population Groups in a Cross-Sectional Sample. [PDF]
Lemmon B +9 more
europepmc +1 more source
Cancer‐associated mutations in endometriosis reframe a benign disease through molecular oncology
This review aims to comprehensively analyse cancer‐associated somatic mutations (CAMs) present in endometriotic lesions, emphasizing their biological roles, spatial distribution and implications for translational applications in medicine. By contextualizing a benign state within a genomic framework, this analysis seeks to establish its value as a ...
Clarissa Mujacic +15 more
wiley +1 more source
Information Needs for HPV Vaccination Among Different Female Population Groups in China. [PDF]
Li X +5 more
europepmc +1 more source
Dietary Habits and Nutritional Status of Different Population Groups in Relation to Lifestyle Factors and Nutritional Knowledge. [PDF]
Wawrzyniak A, Pietruszka B.
europepmc +1 more source
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach +9 more
wiley +1 more source
Characterizing the informativeness of pathogen genome sequence datasets about transmission between population groups. [PDF]
Tran-Kiem C +3 more
europepmc +1 more source
PFAS levels and exposure determinants in sensitive population groups. [PDF]
Fábelová L +26 more
europepmc +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source

